Skip to main content
. 2015 Dec 8;7(1):995–1013. doi: 10.18632/oncotarget.6493
CYP24A1 F: 5′ GCA CAA GAG CCT CAA CAC CAA 3′
R: 5′ AGA CTG TTT GCT GTC GTT TCC A 3′
VDR F: 5′ ATA AGA CCT ACG ACC CCA CCT A 3′
R:GGA CGA GTC CAT CAT GTC TGA A 3′
CYP27B1 F: 5′ CAG TCC ATC CTG GGA AAT GTG A 3′
R: 5′ ACC ACA GGG TAC AGT CTT AGC A 3′
DUSP10 F: 5′ TTG AGT TCA TTG AGG AAG CTC ACC 3′
R: 5′ AAC TCT AGC AAC TGC CCC ATG AAG 3′
CAMP F: 5′TTC AAG AAG GAC GGG CTG GTG AAG 3′
R: 5′ GTC CTG GGT ACA AGA TTC CGC AAA 3′
GAPDH F: 5′ CTC CTC TGA CTT CAA CAG CG 3′
R: 5′GCC AAA TTC GTT GTC ATA CCA G 3′